Showing results (161-170 of 193) with videos related to
Sort By:
Pageof 20
Current Medical Research and Opinion|May 29, 2024
Evaluation of the efficacy and safety of nivolumab in the second- or later-line treatment of patients with locally advanced/metastatic non-small cell lung cancer in Türkiye: a retrospective multicenter non-interventional registry studyNuri Karadurmus, Muhammet Ali Kaplan, Mehmet Ali Nahit Sendur, et al.Medicine|December 23, 2022
Crizotinib efficacy and safety in patients with advanced NSCLC harboring MET alterations: A real-life data of Turkish Oncology GroupMustafa Gürbüz, Saadettin Kiliçkap, Ahmet Bilici, et al.Journal of Gastrointestinal Cancer|February 4, 2021
Trastuzumab ± Capecitabine Maintenance After the First-Line Treatment of HER2-Positive Advanced Gastric Cancer: Retrospective Observational Real-Life Data of Turkish Oncology GroupMustafa Gürbüz, Erman Akkuş, Abdullah Sakin, et al.Tumori|November 10, 2020
Combination of trastuzumab and taxane-containing intensified chemotherapy in first-line treatment of HER2-positive advanced gastric cancerMustafa Gürbüz, Erman Akkuş, Abdullah Sakin, et al.Scientific Reports|November 29, 2025
Treatment outcomes of sunitinib and/or pazopanib in advanced alveolar soft part sarcoma: A Turkish Oncology Group (TOG) studyZehra Sucuoğlu İşleyen, Seval Ay, Ertuğrul Bayram, et al.Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|October 25, 2020
Efficacy of regorafenib in the second-and third-line setting for patients with advanced hepatocellular carcinoma: A real life data of multicenter study from TurkeyMuhammet Bekir Hacioglu, Osman Kostek, Senem Karabulut, et al.Cancers|February 13, 2026
Real-World Treatment Patterns and Survival in Uveal Melanoma: A Multicenter Cohort Study by the Turkish Oncology Group (TOG)Sercan On, Selin Cebeci, Zeynep Hande Turna, et al.European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|May 25, 2024
Real-world evaluation of nivolumab in patients with non-nasopharyngeal recurrent or metastatic head and neck cancer: a retrospective multi-center study by the Turkish Oncology Group (TOG)Arif Akyildiz, Deniz Can Guven, Baris Koksal, et al.European Journal of Cancer Care|September 1, 2020
Worse patient-physician relationship is associated with more fear of cancer recurrence (Deimos Study): A study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG)Ali Alkan, Arzu Yaşar, Zeynep Gülsüm Güç, et al.Journal of Cancer Research and Clinical Oncology|July 31, 2021
The real-life efficacy and safety of osimertinib in pretreated advanced non-small cell lung cancer patients with T790M mutation: a Turkish Oncology Group StudyMutlu Hizal, Burak Bilgin, Nail Paksoy, et al.Pageof 20